Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Common Equity (2020 - 2025)

Historic Common Equity for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to $18.5 million.

  • NeuroPace's Common Equity rose 8851.67% to $18.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.5 million, marking a year-over-year increase of 8851.67%. This contributed to the annual value of $8.0 million for FY2024, which is 6120.36% down from last year.
  • Per NeuroPace's latest filing, its Common Equity stood at $18.5 million for Q3 2025, which was up 8851.67% from $19.4 million recorded in Q2 2025.
  • In the past 5 years, NeuroPace's Common Equity registered a high of $88.7 million during Q2 2021, and its lowest value of -$156.4 million during Q1 2021.
  • In the last 5 years, NeuroPace's Common Equity had a median value of $21.2 million in 2023 and averaged $24.8 million.
  • As far as peak fluctuations go, NeuroPace's Common Equity soared by 16144.94% in 2021, and later plummeted by 6230.51% in 2023.
  • NeuroPace's Common Equity (Quarter) stood at $73.5 million in 2021, then tumbled by 52.69% to $34.8 million in 2022, then plummeted by 40.61% to $20.7 million in 2023, then crashed by 61.2% to $8.0 million in 2024, then skyrocketed by 131.1% to $18.5 million in 2025.
  • Its last three reported values are $18.5 million in Q3 2025, $19.4 million for Q2 2025, and $24.3 million during Q1 2025.